Rivaroxaban or aspirin for extended treatment of venous thromboembolism

EINSTEIN CHOICE Investigators, J. I. Weitz*, A. W.A. Lensing, M. H. Prins, R. Bauersachs, J. Beyer-Westendorf, H. Bounameaux, T. A. Brighton, A. T. Cohen, B. L. Davidson, H. Decousus, M. C.S. Freitas, G. Holberg, A. K. Kakkar, L. Haskell, B. Van Bellen, A. F. Pap, S. D. Berkowitz, P. Verhamme, P. S. WellsP. Prandoni

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

583 Citations (Scopus)
113 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Rivaroxaban or aspirin for extended treatment of venous thromboembolism'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science